Get your Expert Opinion on Investigational Drugs paper right the first time: a ready-made structure with the right abstract and citations, so editors see your science, not formatting slips.
4.5
Authored by Sumalatha Gangadhar | Published on 11 August, 2026
Submitting to Expert Opinion on Investigational Drugs goes smoothly when your draft already matches the journal's own rules. Editors screen new manuscripts against the Expert Opinion on Investigational Drugs guide for authors before peer review, so formatting, structure, and required statements should be right on the first draft rather than repaired during upload. This template sets that structure up for you.
It is a manuscript shell aligned to Expert Opinion on Investigational Drugs. It covers front matter, the abstract the journal expects, a body organized to the journal's article types, and a reference list in the journal's required style. Confirm current scope and article types on the Expert Opinion on Investigational Drugs journal page before you draft.
Prepare the title, authors, affiliations, and ORCID iDs. Write the abstract to the journal's rule and word limit, organize the body to the article type, and apply the required reference style from the first citation. Complete every declaration (ethics, competing interests, funding, data availability) the Expert Opinion on Investigational Drugs guide for authors lists, and cite figures and tables in order.
The common failure modes are formatting or reference style that does not match the guide for authors, missing required statements, and an incomplete portal checklist. Clear all three against the Expert Opinion on Investigational Drugs guide for authors before you submit.
The shell mirrors what editorial staff check first: article-type fit, the abstract rules, required declarations, and the journal's reference style. For more detail see the author resources. When your draft is ready, upload it through the journal's submission system.
| Element | Expert Opinion on Investigational Drugs requirement |
|---|---|
| Abstract | Structured abstract required, maximum 200 words. Structure varies by article type: - Review articles: Introduction (describe significance of topic), Areas covered (research discussed and literature search), Expert opinion (author's expert view on current status of field). - Drug evaluations: Introduction (describe significance of topic), Areas covered (research discussed and literature search), Expert opinion (summarize Expert opinion section). - Original research: Background (reason for study), Research design and methods (study population/setting, blinding, comparators, dosage, treatment regimens/durations, efficacy/safety issues, main outcome measures), Results (efficacy results and adverse events), Conclusions (qualified by limitations), Trial Registration (if applicable). References must not be included in the abstract |
| Main text | Word limits vary by article type: - Review articles: Maximum 7000 words (body of article). - Drug evaluations: 3000 words (not including tables, figures, and references). - Original research: No specific word limit stated in the guidelines. Expert Opinion section: Minimum 500 words for review articles. All article types: Maximum of 5 figures and 5 tables permitted. Review articles: Around 100 references suggested. Drug evaluations: Maximum of 100 references suggested |
| Declarations | Ethics approval/consent as applicable; competing interests; funding; data availability |
| Figures/tables | Publication-ready; cited in order |
| Supplemental | Upload separately when used |
| Keywords | 4-10 keywords in alphabetical order for review articles; 4-6 keywords in alphabetical order for original research; brief list of keywords for drug evaluations. Keywords encompass therapeutic area, mechanism(s) of action, key compounds, etc. The journal instructions state '5-8 keywords' as a general guideline |
| References | NLM (National Library of Medicine) style - Taylor & Francis Standard Reference Style based on National Library of Medicine and National Information Standards Organization standards (Citing Medicine). Numerical in-text citations with bracketed numbers numbered consecutively in order of appearance. Important references should be annotated with one/two-star system (* = of interest, ** = of considerable interest) with brief explanation |
| Peer review | Double-blind peer review (also referred to as double-anonymous peer review). The journal explicitly states: 'Once your paper has been assessed for suitability by the Editorial Team, it will then be double-anonymous peer-reviewed by independent, expert referees.' |
| Submission | rp.tandfonline.com/submission/create?journalCode=IEID |
Read the Expert Opinion on Investigational Drugs guide for authors once before drafting and once before upload. Draft the abstract after results are stable. Set the reference style before adding citations. Keep a cover letter that states your contribution and fit to Expert Opinion on Investigational Drugs in under a page.
Skim two or three recent Expert Opinion on Investigational Drugs papers to calibrate depth and figure style. Make the novelty clear in the first two pages. Deposit data and code when the policy on the Expert Opinion on Investigational Drugs journal page requires it. Disclose any preprint or conference version with identifiers in the cover letter.
Do one focused pass against the Expert Opinion on Investigational Drugs guide for authors: scope, length, reference style, required declarations, and figure quality. Then submit through the journal's submission system.